Objective: To evaluate the incidence and development of valvular regurgitation and its effect on racing performance in Standardbred trotters from 2 to 3.5 years of age.
Design: Longitudinal observational study.
Animals: 103 horses.
Procedure: Horses were examined via echocardiographic imaging 4 times at 6-month intervals. Two-dimensional and M-mode echocardiographic examinations were performed in each horse, and color Doppler imaging was used to detect and evaluate regurgitant blood flow at each valve.
Results: For all cardiac valves, the frequency of valvular regurgitation increased significantly during the 18-month study period. Regurgitation was mild in all valves in which it was detected, and no progression in severity was observed at any valve. Tricuspid regurgitation was more prevalent in horses that raced regularly and was diagnosed more frequently in males and horses with larger left ventricular mass and left ventricular internal diameter during diastole. No relationship between racing performance and valvular regurgitation was observed.
Conclusions And Clinical Relevance: The incidence of valvular regurgitation increased during the study period, and it was common at 3.5 years of age. It was not possible to determine whether the increase was a result of maturity or training. The study revealed that there is a high prevalence of mild valvular regurgitation at this age, but apparently, the regurgitation had no effect on racing performance in this age group. Whether regurgitation will progress or influence future performance is not known.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2460/javma.2005.227.1630 | DOI Listing |
J Cardiovasc Dev Dis
December 2024
2nd Cardiology Department, Interbalkan Medical Center, 55535 Thessaloniki, Greece.
Background: Mitral regurgitation (MR) is a common valvular disorder linked to high morbidity and mortality. For patients unsuitable for surgery, transcatheter mitral edge-to-edge repair (TEER) with the MitraClip G4 system offers an alternative. This study aims to evaluate procedural, echocardiographic, functional, and quality of life (QoL) outcomes in patients who underwent TEER with the MitraClip G4 system, along with possible predictors of New York Heart Association (NYHA) class I at 30 days and at 1 year.
View Article and Find Full Text PDFJ Magn Reson Imaging
January 2025
Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden.
Background: Real-time (RT) phase contrast (PC) flow MRI can potentially be used to measure blood flow in arrhythmic patients. Undersampled RT PC has been combined with online compressed sensing (CS) reconstruction (CS RT) enabling clinical use. However, CS RT flow has not been validated in a clinical setting.
View Article and Find Full Text PDFESC Heart Fail
January 2025
Department of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf, Duesseldorf, Germany.
Aims: Ischaemic mitral regurgitation (MR) is a dynamic condition influenced by global and regional left ventricular remodelling as well as mitral valvular deformation. Exercise testing plays a substantial role in assessing the haemodynamic relevance of MR and is recommended by current guidelines. We aimed to assess the prevalence, haemodynamic consequences, and prognostic impact of dynamic MR using isometric handgrip exercise.
View Article and Find Full Text PDFInt J Obstet Anesth
November 2024
Department of Anesthesiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
Background: Arterial switch operation (ASO) for dextro-transposition of the great arteries was developed four decades ago, and women with ASO have reached childbearing age. Although over 40% of the pregnant women who received ASO gave birth via cesarean delivery, detailed information about anesthesia management has not been reported. This study aimed to evaluate anesthesia and perioperative outcomes in pregnant women with ASO undergoing cesarean delivery.
View Article and Find Full Text PDFJ Am Heart Assoc
January 2025
Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center Albert Einstein College of Medicine Bronx NY USA.
Background: Valvular heart disease (VHD) is a major focus of cardiovascular medicine, but limited data are available for racial and ethnic minorities. The aim was to assess the burden and clinical correlates of VHD in a highly diverse area of the United States.
Methods And Results: Individuals with echocardiographic diagnosis of native VHD between January 2010 and December 2019 at a quaternary care health system of the Bronx (New York, USA) were included.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!